Description
Updated results of the TAGS trial reinforce the clinical benefit and safety of TAS-102 in patients with advanced gastric cancer
€2.42
Updated results of the TAGS trial reinforce the clinical benefit and safety of TAS-102 in patients with advanced gastric cancer
Reviews
There are no reviews yet.